Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year. The company reported $4.20 million in sales this quarter. This is a 26.66K percent
Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it had acquired
Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, is expanding its manufacturing and
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.
Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that it has purchased a $1.0
Zomedica Corp (NASDAQ: ZOM) shares are trading lower by 4.99% at $0.20. The company reported first-quarter earnings results during Tuesday’s after-hours session.
Zomedica reported a first-quarter EPS loss of four tenths of one cent on revenue of $3.751 million.
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.